Skip to content

Aortic Valve Replacement via Mini-Sternotomy and Rapid Deployment Valves: Are We on the Right Track?

Aug 2026 · Revista Argentina de Cardiología · 0 citations · 9 references

TL;DR

The combination of RDV and a minimally invasive approach proved to be safe, with low morbidity and mortality and excellent short-term hemodynamic improvement.

Abstract

Background: Aortic stenosis (AS) is the most common valvular heart disease in developed countries, and its management has evolved toward techniques that reduce surgical risk and accelerate recovery, especially in elderly patients. Among these innovations are rapid deployment valves (RDV), which combine the durability of conventional surgical prostheses with anchoring mechanisms derived from transcatheter aortic valve implantation (TAVI), reducing cardiopulmonary bypass (CPB) and aortic clamping times and facilitating minimally invasive approaches such as mini sternotomy. Objectives: The objective of this study was to evaluate 30-day and 1-year mortality following aortic valve replacement (AVR) via mini-sternotomy using INTUITY RDV. Secondary objectives included the analysis of intraoperative and postoperative complications and trans prosthesis gradients during the first 30 days after surgery. Methods: A single-center, retrospective, observational study was conducted, including 47 patients between 50 to 85 years of age who underwent surgery for severe AS between 2018 and 2024. All patients underwent AVR with INTUITY RDV via mini sternotomy. Clinical, intraoperative, and postoperative variables were analyzed, together with pre-and post-implantation transprosthetic gradients. Results: The procedures were successfully completed in 100% of cases, with no conversions to full sternotomy. Median CPB time was 90 minutes, and median clamping time was 65 minutes. The incidence of paravalvular leak was minimal. In the postoperative course, atrial fibrillation was the most common complication (40.4%). Median hospital length of stay was 7 days. No myocardial infarctions, pacemaker implantations, or 30-day mortality were recorded, while one-year mortality was 2.1%. The hemodynamic results were favorable: the maximum gradient decreased from 73.9 ± 21.3 mmHg to 17.2 ± 6.9 mmHg, and the mean gradient from 44.5 ± 13.3 mmHg to 8.6 ± 3.7 mmHg (p < 0.001 in both cases). No cases of thrombosis or moderate-to-severe paravalvular leak were observed. Conclusion: The combination of RDV and a minimally invasive approach proved to be safe, with low morbidity and mortality and excellent short-term hemodynamic improvement.

View source

Similar papers

Open access Sep 2026

Surgery that looks like transcatheter aortic valve implantation: the transaxillary concept for minimally invasive aortic valve replacement in 1,848 consecutive patients

Background The transaxillary (TxA) approach for minimally invasive aortic valve replacement (MICS-AVR) is a sternum-sparing technique that combines surgical valve replacement with virtually no visible scarring. We report institutional outcomes of the first 1,848 consecutive TxA MICS-AVR procedures. Methods This retrosp...

S. Arzt, K. Alexiou, Ali Taghizadeh-Waghefi et al. · 0 citations
Open access Feb 2026

Transcatheter aortic valve-in-valve implantation for failed surgical aortic bioprostheses using the Navitor platform: early outcomes in a consecutive single-center cohort

Introduction Transcatheter heart valve implantation into a failed surgical heart valve (THV-in-SHV) is an established reintervention strategy for degenerated aortic bioprostheses; however, early procedural outcomes, discharge hemodynamics, and standardized safety remain clinically relevant in routine practice. Material...

R. Sobczyński, J. Trębacz, Paweł Kleczyński et al. · 0 citations
Open access Sep 2026

Rapid-Deployment Versus Sutured Aortic Valve Replacement Through Right Anterior Thoracotomy: A Single-Team Retrospective Comparison of Operative Efficiency in 192 Consecutive Patients

Minimally invasive aortic valve replacement through a right anterior thoracotomy is limited by prolonged operative times. We assessed whether a rapid-deployment prosthesis reduces those times and improves early outcomes when surgical access, team and era are held constant. Single-centre retrospective cohort study of 20...

Ł. Jaworski, K. Jarmoszewicz, A. Kowalówka et al. · 0 citations
Open access Aug 2026

Early Hemodynamic Performance of the Epic™ Max Triple Composite Porcine Aortic Valve: A Benchmark for Future Valve-in-Valve Interventions

Lifetime management of aortic stenosis has become a major focus of ongoing research. As valve-in-valve (ViV) procedures gain more relevance, pre-emptive surgical valve selection plays a key component of long-term planning. We report our early hemodynamic experience with the porcine Epic Max valve, which was enginee...

M. Al-Tawil, Abdel Hannan Diab, Tobias T. Krause et al. · 0 citations
Review Sep 2026

Aortic valve replacement in patients with small aortic annuli: a systematic review and network meta-analysis.

Objectives Up to 40% of patients with aortic stenosis undergoing valve replacement have a small annulus, a key determinant of valve hemodynamics, durability, and clinical outcomes. Surgical and transcatheter approaches have been reported to be determined by prosthesis design, considering the operative mortality and mor...

J. Chiabrando, M. Lombardi, E. Elia et al. · 0 citations
Open access Aug 2026

Early Multicenter Outcomes of Dedicated Transcatheter Aortic Valve Replacement for Left Ventricular Assist Device‐Associated Pure Aortic Regurgitation

ABSTRACT Background Aortic regurgitation (AR) is a frequent and clinically relevant complication in patients with left ventricular assist devices (LVAD), impairing circulatory support and worsening outcomes. Surgical aortic valve replacement often carries prohibitive risk in this population, while conventional transcat...

H. Hinkov, Sara Yousefzada, I. Just et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.